Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parotid Oncocytomas Express the Glycoprotein Non-metastatic Melanoma Protein B (GPNMB): A Potential Link with Birt-Hogg-Dubé Syndrome.

Head and neck pathology·2026
Same author

Performance of Automated Hematology Analyzer Criteria in Detecting Peripheral Blood Smear Abnormalities: A Systematic Literature Review.

International journal of laboratory hematology·2026
Same author

Practical Considerations in the Implementation of Peripheral Smear Review in the Clinical Laboratory.

International journal of laboratory hematology·2026
Same author

Splenogonadal Fusion.

Mayo Clinic proceedings·2026
Same author

Imaging Mass Spectrometry-Based Assessment of ER, PR, and HER2 Protein Expression in Breast Cancer.

Proteomics·2026
Same author

Paroxysmal Nocturnal Hemoglobinuria in Pregnancy Treated With Pegcetacoplan: Case Report and Pharmacokinetic Analysis.

EJHaem·2025

Related Experiment Video

Updated: Dec 14, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K

A multicenter study evaluation of the ClearLLab 10C panels.

Benjamin D Hedley1, Guoyan Cheng2, Michael Keeney1

  • 1Department of Pathology and Laboratory Medicine, London Health Sciences Center, London, Ontario, Canada.

Cytometry. Part B, Clinical Cytometry
|July 16, 2020
PubMed
Summary

The ClearLLab 10C Panels accurately detect hematological malignancies in patients. This multiparameter flow cytometry tool showed high sensitivity and specificity, making it reliable for clinical diagnosis.

Keywords:
flow cytometryimmunophenotypingleukemialymphomamultiparameter

More Related Videos

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.4K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.1K

Related Experiment Videos

Last Updated: Dec 14, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.4K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.1K

Area of Science:

  • Hematology
  • Immunology
  • Clinical Diagnostics

Background:

  • Multiparameter flow cytometry is crucial for diagnosing and monitoring hematological malignancies.
  • Accurate phenotyping is essential for effective patient management.

Purpose of the Study:

  • To evaluate the performance of the ClearLLab 10C Panels for identifying suspected hematological malignancies.
  • To assess the diagnostic accuracy and agreement with existing methods.

Main Methods:

  • A multicenter study involving 453 patient specimens (peripheral blood, bone marrow, lymph node).
  • Comparison of ClearLLab 10C Panels against laboratory-developed tests (LDTs) and final clinical diagnosis.
  • Utilized four 10-color reagent panels for B-lineage, T-lineage, and myeloid lineage analysis.

Main Results:

  • The ClearLLab 10C Panels demonstrated a diagnostic sensitivity of 96% and specificity of 95% compared to final clinical diagnosis.
  • Excellent agreement (98%) was observed between ClearLLab 10C phenotyping and LDTs.
  • Minor discrepancies were attributed to detection limits, clinical information, or panel markers.

Conclusions:

  • The ClearLLab 10C Panels are a reliable tool for assessing the presence or absence of malignancy in suspected cases.
  • These panels can be adopted by laboratories to aid in the diagnosis of hematological malignancies.
  • The study confirms the utility of these panels in routine clinical practice.